DVA DaVita Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DVA DaVita prior to the earnings report this week,
I would consider purchasing the 175usd strike price Puts with
an expiration date of 2025-2-21,
for a premium of approximately $8.45.
If these options prove to be profitable prior to the earnings
13,665.23
0.06 BRL
5.05 B BRL
69.09 B BRL
About DaVita Inc.
Sector
Industry
CEO
Javier J. Rodriguez
Website
Headquarters
Denver
Founded
1994
ISIN
BRDVAIBDR002
FIGI
BBG00P14JWQ5
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
THC Tenet Healthcare Corp Financial
- Company has grown fast.
- Outperforming the market in general.
- Good outlook for the coming time.
Techinical
- Good risk-reward setup.
- Sector is in favor by many investors.
- Other stocks in the sector are just like this stock outperforming the market and I think this will co
DVA DaVita Inc (Long) Financial
- Company shows great results.
- Company passed the Hanhart fundamental growth test.
- Earnings + outlook + 10%.
- Growth outlook is one of the bests in these times.
Marco
- Company seems to perform well in most market conditions that are coming up.
Techincal
- Company is outpe
DaVita Inc. DaVita Inc. (NYSE: DVA) currently sits at a pivotal point, poised for potential growth. The RSI (14) is neutral at 43.97, indicating neither an overbought nor oversold condition. This neutrality often precedes a directional move, making DVA a prime candidate for a strategic entry.
The stock closed
DaVita (DVA) AnalysisLeading Dialysis Service Provider:
DaVita NYSE:DVA stands as a top kidney dialysis service provider in the U.S., demonstrating strong resilience post-COVID-19. CEO Javier Rodriguez emphasized the company's strengthened position and continued investments in staff and systems.
Expansive Market Pote
DVA LONG 041824I understand there may be some noise in the market regarding weight loss drugs, as such it has created a bit of a rift in prices of healthcare services relating to patient diets, lifestyles and procedures, could also be COVID lag/residue etc.
At this time however the Senior Living sector is expecte
DaVita (DVA) Stock Spike on Hope for Chronic Kidney Disease CureDaVita ( NYSE:DVA ) stock witnessed a significant surge as Novo Nordisk (NVO) unveiled promising results from its weight-loss drug study, offering newfound hope for patients battling chronic kidney disease. The groundbreaking findings have ignited investor optimism and reshaped the landscape for dia
A 80% edge - Mostly unused. Why?The Medianline/Pitchfork Tool provides a high probability (~80%) to reach the Centerline from any parallel line.
That means, if you can figure out how to buy as low as possible, or short as high as possible, your trade works out ~80% of time.
Why would one not use this edge?
Ask me questions, I
FlagEarnings 2-22 AMC.
Price has broken up from a triangle and looks to be forming a flag.
Earnings close and there has been some Medicare reimbursement issues which could affect earnings.
No recommendation.
EPS (FWD)
6.40
PE (FWD)
12.96
Div Rate (TTM)
-
Short Interest
3.04%
Market Cap
$7.47B
DaVita
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
DVA5026985
DaVita Inc. 3.75% 15-FEB-2031Yield to maturity
7.13%
Maturity date
Feb 15, 2031
DVA5876396
DaVita Inc. 6.875% 01-SEP-2032Yield to maturity
6.59%
Maturity date
Sep 1, 2032
DVA4994310
DaVita Inc. 4.625% 01-JUN-2030Yield to maturity
6.56%
Maturity date
Jun 1, 2030
See all DVAI34 bonds